Walleye Capital
AKYA

Walleye Capital’s Akoya BioSciences AKYA Stock Holding History

Walleye Capital’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63,354
Closed -$468K – 4821
2023
Q2 		$468K Buy
+63,354
New +$423K ﹤0.01% 2491
2021
Q3 		– Sell
-30,687
Closed -$593 – 1571
2021
Q2 		$593 Buy
+30,687
New +$634K 0.02% 698

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Walleye Capital's AKYA Position: Q3 2023 in Review

Walleye Capital sold out of Akoya BioSciences (AKYA) in Q3 2023, closing a stake of 63,354 shares — an estimated $468K sold.

Walleye Capital first reported a position in AKYA in Q2 2021 and held it in 2 quarters. The position peaked at $468K in Q2 2023. 62 funds tracked by Wall St. Rank hold AKYA as of Q3 2023.

  • Walleye Capital reported no remaining Akoya BioSciences position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 63,354 Akoya BioSciences shares in Q3 2023, an estimated $468K.
  • Walleye Capital first reported a position in Akoya BioSciences in Q2 2021 and held it in 2 quarters.
  • Walleye Capital's Akoya BioSciences position peaked at $468K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.